Table 3.
OS |
PFS |
|||
---|---|---|---|---|
Variable | Relative risk | P | Relative risk | P |
Univariate | ||||
Age | 1.00 | 0.84 | 1.01 | 0.81 |
Haemoglobin | 1.13 | 0.41 | 1.15 | 0.33 |
Calcium | 1.04 | 0.84 | 0.76 | 0.23 |
Performance status = 1 | 0.63 | 0.29 | 0.74 | 0.47 |
Pathology = mixed | 0.75 | 0.54 | 0.58 | 0.20 |
No. organs involved ≥ 2 | 0.92 | 0.86 | 0.85 | 0.74 |
Metastasis in lung | 0.51 | 0.08 | 0.46 | 0.04 |
Metastasis in lymph node | 2.00 | 0.09 | 1.67 | 0.20 |
Metastasis in renal bed | 1.33 | 0.54 | 1.84 | 0.19 |
Metastasis in bone | 1.08 | 0.90 | 1.28 | 0.69 |
Metastasis in other | 0.77 | 0.73 | 0.74 | 0.69 |
Therapy before surgery = No IL-2 | 0.64 | 0.25 | 0.66 | 0.26 |
Therapy duration, months | 0.97 | 0.62 | 1.01 | 0.90 |
Log (time first diagnosis to mets) | 1.17 | 0.19 | 1.13 | 0.24 |
Log (time mets to surgery) | 1.36 | 0.48 | 1.37 | 0.42 |
No. sites of surgery ≥ 2 | 0.98 | 0.97 | 0.87 | 0.83 |
Lung at surgery | 0.64 | 0.25 | 0.59 | 0.16 |
Lymph node at surgery | 1.79 | 0.16 | 1.60 | 0.25 |
Renal bed at surgery | 1.21 | 0.70 | 1.57 | 0.37 |
Bone at surgery | 1.08 | 0.90 | 1.28 | 0.69 |
Other at surgery | 0.47 | 0.47 | 0.39 | 0.36 |
Not NED after surgery | 7.02 | < 0.001 | 8.71 | < 0.001 |
Multivariate | ||||
Not NED after surgery | 6.06 | < 0.001 | 13.98 | < 0.001 |
Metastasis in lung | 0.62 | 0.003 | 0.30 | 0.003 |
met, metastases.